The Burden of Infant Meningococcal Disease in the United States
- PMID: 23687573
- PMCID: PMC3656548
- DOI: 10.1093/jpids/pir003
The Burden of Infant Meningococcal Disease in the United States
Figures




Similar articles
-
Neonatal meningococcal disease in the United States, 1990 to 1999.Pediatr Infect Dis J. 2003 May;22(5):418-22. doi: 10.1097/01.inf.0000066876.77453.04. Pediatr Infect Dis J. 2003. PMID: 12792381
-
Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease.Clin Infect Dis. 2010 Jan 15;50(2):184-91. doi: 10.1086/649209. Clin Infect Dis. 2010. PMID: 20001736
-
History of Meningococcal Outbreaks in the United States: Implications for Vaccination and Disease Prevention.Pharmacotherapy. 2016 Aug;36(8):880-92. doi: 10.1002/phar.1790. Pharmacotherapy. 2016. PMID: 27332671 Review.
-
Opportunities for control of meningococcal disease in the United States.Annu Rev Med. 2004;55:333-53. doi: 10.1146/annurev.med.55.091902.103612. Annu Rev Med. 2004. PMID: 14746525 Review.
-
Population-based analysis of meningococcal disease mortality in the United States: 1990-2002.Pediatr Infect Dis J. 2006 Mar;25(3):191-4. doi: 10.1097/01.inf.0000202065.03366.0c. Pediatr Infect Dis J. 2006. PMID: 16511378
Cited by
-
Optimal use of meningococcal serogroup B vaccines: moving beyond outbreak control.Ther Adv Vaccines Immunother. 2018 Jun 21;6(3):49-60. doi: 10.1177/2515135518781757. eCollection 2018 May. Ther Adv Vaccines Immunother. 2018. PMID: 30182092 Free PMC article. Review.
-
Rationale for the Development of a Pentavalent Meningococcal Vaccine: A US-Focused Review.Infect Dis Ther. 2022 Jun;11(3):937-951. doi: 10.1007/s40121-022-00609-9. Epub 2022 Mar 31. Infect Dis Ther. 2022. PMID: 35357651 Free PMC article. Review.
-
Diagnosis and Treatment of Childhood Meningitis Caused by Streptococcus bovis Group.Curr Infect Dis Rep. 2016 Mar;18(4):11. doi: 10.1007/s11908-016-0519-8. Curr Infect Dis Rep. 2016. PMID: 26879740
-
[Health Technology Assessment of meningococcal B vaccine (Trumenba®) in adolescent in Italy].J Prev Med Hyg. 2019 Dec 19;60(3 Suppl 2):E1-E94. doi: 10.15167/2421-4248/jpmh2019.60.3s2. eCollection 2019 Dec. J Prev Med Hyg. 2019. PMID: 32047867 Free PMC article. Italian. No abstract available.
-
Preventing invasive meningococcal disease in early infancy.Hum Vaccin Immunother. 2022 Nov 30;18(5):1979846. doi: 10.1080/21645515.2021.1979846. Epub 2022 Apr 28. Hum Vaccin Immunother. 2022. PMID: 35482946 Free PMC article. Review.
References
-
- Sáez-Llorens X, McCracken GH., Jr. Bacterial meningitis in children. Lancet. 2003;361:2139–48. - PubMed
-
- Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children—United States, 1998–2000. MMWR Morb Mortal Wkly Rep. 2002;51:234–7. - PubMed
-
- Pilishvili T, Lexau C, Farley MM, et al. Active Bacterial Core Surveillance/Emerging Infections Program Network. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010;201:32–41. - PubMed
-
- Bilukha OO, Rosenstein N. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep. 2005;54:1–21. - PubMed
-
- Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices. Revised recommendations of the Advisory Committee on Immunization Practices to vaccinate all persons aged 11–18 years with meningococcal conjugate vaccine. MMWR Morb Mortal Wkly Rep. 2007;56:794–5. - PubMed
LinkOut - more resources
Full Text Sources